Penumbra (PEN) shares of the healthcare supplies name are coiling in a narrow price wedge inside its value area this month and seeing MACD cross bullish now for a potential thrust up through 275 that can target 290 and 300 on the upside. PEN has held up well in the market chaos as it did not close below the 255 level and has remained positive year to date currently up +15% as a more defensive value name that should hold up well in volatility. PEN is growing sales impressively by at least +13% through FY27.